3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Rituximab
21
Cyclophosphamide
15
Etoposide
11
Vincristine
9
Prednisone
9
Doxorubicin
8
Cytarabine
8
Filgrastim
7
Radiotherapy
6
Peripheral Blood Stem Cell Transplantation
6
fludarabine phosphate
5
Melphalan
5
Dexamethasone
4
Carmustine
4
Bendamustine Hydrochloride
4
loncastuximab tesirine
3
ibrutinib
3
Tacrolimus
3
Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Gemcitabine
3
Calcium Dobesilate
3
CT-P10
3
Busulfan
3
venetoclax
2
sargramostim
2
polatuzumab vedotin
2
pembrolizumab
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Lymphoma, Large B-Cell, Diffuse
×
Hand Strength
×
Clear all
NCT04293900
2020-10-06
R-CHOP-OS
George Washington University
Withdrawn